迴天新材(300041.SZ):第三期員工持股計劃股票出售完畢
格隆匯7月11日丨迴天新材(300041.SZ)公佈,2023年7月10日至2025年7月10日期間,公司第三期員工持股計劃所持有的18,684,724股公司股票,在各鎖定期屆滿後已通過大宗交易和集中競價的方式分批次出售完畢,佔公司當前總股本的3.34%。其中大宗交易的受讓方與公司持股5%以上股東、實際控制人不存在關聯關係或者一致行動關係。本員工持股計劃實施期間,公司嚴格遵守市場交易規則,遵守中國證監會、深圳證券交易所關於信息敏感期不得買賣股票的規定,不存在利用內幕信息進行交易的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.